Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
Rhea-AI Summary
Teleflex (NYSE:TFX) will hold its Q3 2025 earnings conference call on Thursday, November 6, 2025 at 8:00 a.m. ET to discuss third-quarter results and provide an operational update. Participants should pre-register to receive dial-in information; a live audio webcast will be available at teleflex.com. An audio replay begins at 11:00 a.m. ET on November 6, 2025 and is accessible via the website or by phone at 1 800 770 2030 (U.S./Canada) or 1 609 800 9909 (international) using conference ID 69028.
Teleflex will also host a Vascular Intervention virtual investor meeting on November 14, 2025 at 8:00 a.m. ET to review its recent Vascular Intervention acquisition and product portfolio; pre-registration and a live webcast are available at teleflex.com.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, TFX gained 3.43%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
WAYNE, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 6, 2025.
To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, teleflex.com.
An audio replay of the call will be available beginning at 11:00 am Eastern Time on November 6, 2025, either on the Teleflex website or by telephone. The call can be accessed by dialing 1 800 770 2030 (U.S. and Canada) or 1 609 800 9909 (all other locations). The conference ID is 69028.
Vascular Intervention Virtual Meeting
On November 14, 2025, at 8:00 am Eastern Time, Teleflex will host a virtual meeting to review its recent Vascular Intervention business acquisition, with a focus on the strategic rationale and the comprehensive coronary and peripheral product portfolio.
To participate in the investor event, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, teleflex.com.
About Teleflex Incorporated
As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.
Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™ Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.
At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com.
Contacts:
Teleflex Incorporated:
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
investors.teleflex.com
610-948-2836
FAQ
When is Teleflex (TFX) holding its Q3 2025 earnings conference call?
How can investors access the Teleflex (TFX) November 6, 2025 earnings call?
When will the audio replay of Teleflex's (TFX) Q3 2025 call be available?
What are the dial-in numbers for Teleflex's (TFX) November 6, 2025 replay?
When is Teleflex's (TFX) Vascular Intervention investor virtual meeting?
What will Teleflex (TFX) cover at the November 14, 2025 Vascular Intervention meeting?
